Ignite Creation Date:
2025-12-24 @ 10:55 PM
Ignite Modification Date:
2026-05-05 @ 9:42 AM
Study NCT ID:
NCT06138769
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-07-03
First Post:
2023-11-14
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Lenvatinib After Progression on Atezolizumab-bevacizumab in Hepatocellular Carcinoma
Sponsor:
Organization: